Global Antithrombin Market, By Technology Application (Therapeutics, Research and Diagnostics), Source (Human, Goat Milk and Others), Dosage Form (Lyophilized and Liquid), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Antithrombin Market : Global Antithrombin Market
Rising use of antithrombin in the combined therapy procedures is instilling the rise in the antithrombin market value. Data Bridge Market Research analyses that the antithrombin market will exhibit a CAGR of around 4.6% for the forecast period of 2021-2028.
Antithrombin is a glycoprotein containing 432 amino acids and is produced by the liver. It is a molecule that develops when the enzymes of a coagulation system are deactivated by the liver and the main function of antithrombin being to prevent blood clotting and clogging. A human body has a balance of chemicals that perform designated functions. One such function is clotting and thrombin is an important protein that serves this purpose. Antithrombin is a protein that blocks thrombin. This means that a deficiency of antithrombin in a human body is a blood disorder wherein clots are developed in the veins. Antithrombin is a natural blood thinner and its presence helps to save a human body suffering from a rare disease called thrombosis.
The increasing prevalence of coagulation disorders, congenital antithrombin deficiency, disseminated intravascular coagulation, and extracorporeal membrane oxygenation is fuelling up the growth rate of the antithrombin market. The rise in the number of therapeutic tests coupled with the rising surgical procedures which in turn use antithrombin is also fostering the growth of the market. Technological advancements coupled with the increased expenditure of research and development proficiencies are further fuelling up the growth of the antithrombin market.
However, increased use of biologics is narrowing down the scope of growth for the antithrombin market. The high cost of undergoing an antithrombin procedure is also dampening down the market growth. Thus, alternative solutions available in the market will shift the focus of investors from antithrombin towards them. Lack of adequate technological infrastructure especially in underdeveloped countries will derail the antithrombin market growth. Existing governmental regulations being imposed on animal testing has further hammered down the market growth.
This antithrombin market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on antithrombin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Antithrombin Market Scope and Market Size
The antithrombin market is segmented on the basis of technology application, source and dosage form. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of technology application, the antithrombin market is segmented into therapeutics, research and diagnostics.
- On the basis of source, the antithrombin market is segmented into human, goat milk and others.
- On the basis of dosage form, the antithrombin market is segmented into lyophilized and liquid.
Antithrombin Market Country Level Analysis
The antithrombin market is analysed and market size insights and trends are provided by country, technology application, source and dosage form as referenced above.
The countries covered in the antithrombin market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the antithrombin market and will continue to rise in terms of market share and market revenue during the forecast period. This is because of rising awareness, approval and adoption of antithrombin across countries in this region. Also, rising population with coagulation disorders is further bolstering the growth of antithrombin in this region.
The country section of the antithrombin market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Antithrombin Market Share Analysis
The antithrombin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to antithrombin market.
The major players covered in the antithrombin market report are Grifols, Octapharma AG, LFB USA, CSL, Takeda Pharmaceutical Company Limited., Lee BioSolutions, scrippslabs, Kedrion S.p.A, Diapharma, Koliber Biosciences, exonbio., Green Cross Corp., Helena Laboratories (UK) Limited, MyBioSource.com., Siemens Healthcare Private Limited, Aniara Diagnostica, Sysmex Corporation, Kyowa Kirin Co., Ltd., Janssen Pharmaceuticals, Inc. and Trinity Biotech PLC among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-